TG Therapeutics (TGTX) Misses Q4 EPS by 22c

TG Therapeutics (NASDAQ: TGTX) reported Q4 EPS of ($0.48), $0.22 worse than the analyst estimate of ($0.26).

For earnings history and earnings-related data on TG Therapeutics (TGTX) click here.

You May Also Be Interested In

• FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
• Cerebras Systems posts 94% revenue jump, announces OpenAI deal
• Morgan Stanley upgrades CDW on stronger AI-driven server demand